About Todd Flohr
Todd Flohr is co-founder, chief executive officer and chairman of Salus Scientific. Salus is a medical technology company that protects doctors, nurses and technologists in fluoroscopy suites. He directs the company's strategy and operations. The company grew out of a practicing physician's answer to his own job-related injury. Flohr built a company around that idea. He guided GLiFT from concept to patent and on to a commercial product. U.S. health systems now use it.
Salus has grown from one device to a range that covers occupational wellness services, protective garments and radiation protection. Under Flohr, Salus closed its Series A financing, launched AeroShield commercially and opened two production facilities in South Carolina. Salus announced the close of its $10.1 million Series A on August 5, 2026. Flohr has worked in medical device commercialization for over twenty years. His past employers include Abbott Vascular, AccessClosure, St. Jude Medical, Vital Connect and HeartFlow, where he held senior roles. He earned a B.A. in corporate communications at the College of Charleston.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Todd Flohr in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Todd Flohr works with at each company, as listed on that company's latest Form D.
Todd Flohr in the News
Sources
- SECSalus Scientific Corp. Form D, filed Oct 22, 2026
- wire releaseSalus Scientific Closes Oversubscribed Series A Financing, Raising $10.1 Million (PR Newswire, August 5, 2026)
- wire releaseSalus Scientific Highlights Comprehensive Approach to Procedural Workforce Protection at TCT 2026 (PR Newswire, October 23, 2026)